J P. Waymack, MD (he/him/his)

Senior Chief Medical Officer
Moleculin Biotech, Inc

B.S. Virginia Tech 1974
M.D. Medical College of Virginia 1978
Sc.D. University of Cincinnati 1989
Associate Professor UTMB 1990 - 1993
FDA Medical Officer 1993-1996
Founder and Chairman of the Board of Directors, Kitov Pharmaceuticals 2012 -2018
President, Waymack Consulting 1997- present
Senior Chief Medical Officer Moleculin BioTech 2021 - present

Poster(s):

• (P 183) A PHASE 1B/2 STUDY OF LIPOSOMAL ANNAMYCIN (ANN) IN SUBJECTS WITH PREVIOUSLY TREATED SOFT-TISSUE SARCOMAS (STS) WITH PULMONARY METASTASES